Article Information
PubMed
Print ISSN
Online ISSN
History
- Published online February 17, 2023.
Article Versions
- Earlier version (January 10, 2023 - 12:50).
- You are currently viewing an Earlier version of this article (February 17, 2023 - 13:37).
- View the most recent version of this article
Copyright & Usage
© 2023 The Authors. This is an open access article under the terms of the Creative Commons Attribution Non-Commercial License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited and is not used for commercial purposes.
Author Information
- Charlotte A. Hoogstraten1,
- Jonathan J. Lyon2,
- Jan A.M. Smeitink3,
- Frans G.M. Russel1,*, and
- Tom J.J. Schirris1
- 1Pharmacology and Toxicology, Radboud Institute for Molecular Life Sciences and Radboud Center for Mitochondrial Medicine, Radboud University Medical Center, Netherlands
- 2Investigative Preclinical Toxicity & GSK Mitochondrial Network Lead, GlaxoSmithKline, United Kingdom
- 3Pediatrics, Radboud Center for Mitochondrial Medicine, Radboud University Medical Center and Khondrion BV, Netherlands
- ↵* Corresponding Author:
Frans G.M. Russel, Pharmacology and Toxicology, Radboud Institute for Molecular Life Sciences and Radboud Center for Mitochondrial Medicine, Radboud University Medical Center, Department of Pharmacology and Toxicology, P. O. Box 9101, Nijmegen, N/A, 6500 HB, Netherlands. E-mail: frans.russel{at}radboudumc.nl